These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8492955)

  • 41. The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs.
    Ragni MV; Kingsley LA; Zhou SJ
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):120-6. PubMed ID: 1732503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Myopathy associated with infection by the human immunodeficiency virus type-1 (HIV-1)].
    Gabriel Botella F; Rosello Sastre E; Labios Gómez M; Carda Batalla C; Balaguer Martínez JV; Arnal Babiloni M
    An Med Interna; 1992 Nov; 9(11):557-9. PubMed ID: 1467406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myopathy associated with human immunodeficiency virus (HIV) but not with zidovudine.
    Simpson DM
    Ann Intern Med; 1988 Nov; 109(10):842. PubMed ID: 3190033
    [No Abstract]   [Full Text] [Related]  

  • 45. Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment.
    Cornford ME; Ho HW; Vinters HV
    Acta Neuropathol; 1992; 84(5):516-29. PubMed ID: 1334328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism of Zidovudine.
    Veal GJ; Back DJ
    Gen Pharmacol; 1995 Nov; 26(7):1469-75. PubMed ID: 8690233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zidovudine disposition during hemodialysis in a patient with acquired immunodeficiency syndrome.
    Tartaglione TA; Holeman E; Opheim K; Smith T; Collier AC
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):32-4. PubMed ID: 2293640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment.
    Maehlen J; Dunlop O; Liestøl K; Dobloug JH; Goplen AK; Torvik A
    AIDS; 1995 Oct; 9(10):1165-9. PubMed ID: 8519453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of myopathy in a placebo-controlled zidovudine trial.
    Simpson DM; Slasor P; Dafni U; Berger J; Fischl MA; Hall C
    Muscle Nerve; 1997 Mar; 20(3):382-5. PubMed ID: 9052824
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapy.
    Miller RG
    West J Med; 1994 May; 160(5):447-52. PubMed ID: 8048229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex.
    Mildvan D; Machado SG; Wilets I; Grossberg SE
    Lancet; 1992 Feb; 339(8791):453-6. PubMed ID: 1371323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
    Fischl MA; Richman DD; Causey DM; Grieco MH; Bryson Y; Mildvan D; Laskin OL; Groopman JE; Volberding PA; Schooley RT
    JAMA; 1989 Nov; 262(17):2405-10. PubMed ID: 2677429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Risk of the development of dementia after interruption of zidovudine treatment].
    Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM
    Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
    Till M; MacDonell KB
    Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
    Garavelli PL
    Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
    [No Abstract]   [Full Text] [Related]  

  • 57. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients.
    Mitchell DM; Fleming J; Pinching AJ; Harris JR; Moss FM; Veale D; Shaw RJ
    Am Rev Respir Dis; 1992 Sep; 146(3):745-51. PubMed ID: 1519857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skeletal muscle involvement in human immunodeficiency virus infection: a report of four cases.
    Sangle SA; Dasgupta A; Ratnalikar SD; Kulkarni RV
    Neurol India; 2010; 58(6):939-41. PubMed ID: 21150063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex.
    Glaser JB; Volpe S; Aguirre A; Simpkins H; Schiffman G
    J Infect Dis; 1991 Oct; 164(4):761-4. PubMed ID: 1894937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.